Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,041,053,576
-$180,582,631 QoQ
Shares Held
43,233,122
-0.6% QoQ
Ownership
0.759%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#16
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $26,335,991,083 across 11 Drug Manufacturers - General names. PFE ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,145,229 | $6,171,342,532 | |
| 2 | JNJ |
Johnson & Johnson
|
19,286,904 | $4,898,295,007 | |
| 3 | AZN |
Astrazeneca PLC
|
25,750,245 | $4,882,761,455 | |
| 4 | ABBV |
AbbVie Inc.
|
11,548,053 | $2,905,952,055 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,873,343 | $2,425,224,575 | |
| 6 | AMGN |
Amgen Inc
|
3,816,942 | $1,382,191,036 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,421,131 | $1,316,605,688 | |
| 8 | PFE |
Pfizer Inc
This page
|
43,233,122 | $1,041,053,576 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,041,053,576 | 43,233,122 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,221,636,207 | 43,505,563 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,067,319,201 | 42,864,225 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,063,565,418 | 41,741,186 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $931,901,248 | 38,444,771 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $939,114,184 | 37,060,544 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $979,131,168 | 36,906,565 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,095,724,600 | 37,861,942 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $1,039,733,217 | 37,159,872 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $1,138,274,641 | 41,018,906 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $1,195,716,557 | 41,532,357 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $1,410,105,625 | 42,511,475 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,608,077,609 | 43,840,720 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,703,295,470 | 41,747,438 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,107,644,978 | 41,132,806 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,829,802,913 | 41,814,509 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,243,567,362 | 42,791,672 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $2,146,139,275 | 41,455,269 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,278,652,046 | 38,588,519 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,672,249,098 | 38,880,472 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,464,329,968 | 37,393,513 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,302,801,161 | 35,959,182 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,343,507,353 | 36,498,434 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,337,795,336 | 36,452,225 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,209,319,875 | 36,982,221 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,197,944,051 | 36,701,767 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||